|1.||Agah, Shahram: 4 articles (04/2015 - 04/2007)|
|2.||Hosseini, Vahid: 3 articles (04/2015 - 02/2012)|
|3.||Gao, Wen: 3 articles (10/2014 - 03/2011)|
|4.||Jin, Xi: 3 articles (12/2013 - 03/2011)|
|5.||Xiao, Xilong: 3 articles (12/2013 - 03/2011)|
|6.||Tang, Shusheng: 3 articles (12/2013 - 03/2011)|
|7.||Ebrahimi-Dariani, Naser: 3 articles (12/2010 - 08/2003)|
|8.||John, Sushil M: 3 articles (01/2010 - 01/2009)|
|9.||Sankarapandian, Venkatesan: 3 articles (01/2010 - 01/2009)|
|10.||David, Kirubah V: 3 articles (01/2010 - 01/2009)|
12/01/2007 - "Furazolidone, a nitrofuran derivative, is very effective against the infection with S. "
07/01/2013 - "Significantly more patients had infections eradicated by furazolidone-containing regimens than nonfurazolidone regimens (P = .01). "
03/01/1999 - "Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection."
03/04/2014 - "[Efficacy of triple versus quadruple furazolidone-based eradication regimens for Helicobacter pylori infection]."
11/26/2013 - "[Efficacy of furazolidone-based quadruple therapy as rescue treatment for refractory Helicobacter pylori infection]."
|2.||Bacillary Dysentery (Shigellosis)
01/01/1972 - "Failure of furazolidone therapy in shigellosis."
09/01/1968 - "Furazolidone in the treatment of institutional shigellosis."
01/01/1960 - "The evaluation of furazolidone in the treatment of shigellosis."
07/01/1972 - "Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children."
06/01/1969 - "Use of combined furazolidone and tetracycline in controlling institutional shigellosis."
|3.||Typhoid Fever (Typhoid)
01/01/1994 - "Furazolidone was found to be efficacious, safe and cost-effective in the treatment of most cases of childhood typhoid fever caused by multi-resistant S. "
05/01/1995 - "Furazolidone in typhoid fever--correlation of clinical efficacy with serum bactericidal activity."
03/01/1975 - "Drug trial in enteric fever with furazolidone."
02/01/1998 - "Furazolidone and typhoid fever."
10/01/1997 - "Minimum inhibitory concentration of furazolidone in children with typhoid fever."
09/01/1991 - "These results indicate that furazolidone, given as either a single dose or divided doses for 3 days, is effective treatment for childhood cholera."
09/01/1989 - "A single dose of 400 mg of furazolidone is not therapeutically effective in cholera."
09/01/1991 - "Efficacy of a single dose of furazolidone for treatment of cholera in children."
04/01/2002 - "The appearance of resistance in V. cholerae O139 to furazolidone is a matter of great concern since this drug is used for the treatment of cholera in children and pregnant women."
05/16/1983 - "Furazolidone a synthetic nitrofuran used in the treatment of cholera, was found to cause prophage induction and filament formation in Vibrio cholerae. "
|5.||Duodenal Ulcer (Curling's Ulcer)
04/01/2015 - "METHODS Forty-eight H.pylori-positive patients with proven gastric or duodenal ulcers and/or erosions who had previously failed to respond to furazolidone-containing regimens were enrolled. "
01/01/1990 - "Twenty-eight condensation products of heterocyclic-a-carboaldehydes with N-aminooxazolidones, semicarbazides, thiosemicarbazides and benzoxycarbonyl hydrazide were synthesized so as to deduce the antiulcer pharmacophore or fragment of furazolidone (I), a prototype which has shown therapeutic efficacy in patients with gastric and duodenal ulcers. "
01/01/2015 - "pylori infected patients with proven gastric or duodenal ulcers and /or gastric or duodenal erosions at Imam Khomeini Hospital in Sari/Northern Iran, were randomly allocated into three groups: group A (OABF) with furazolidone (F) (200 mg bid.), group B (OABM-F) metronidazole (M) (500 mg bid.) for the first five days, followed by furazolidone (F) (200 mg bid.) for the second five days and group C (OAF) with furazolidone (F) (200 mg tid.). "
03/01/2000 - "Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease."
04/01/1989 - "This suggested that the protective role of furazolidone against the formation of duodenal ulcer induced by cysteamine in rat may be related to increased DA level in telencephalon."
|2.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|5.||Anti-Bacterial Agents (Antibiotics)
|2.||Fluid Therapy (Oral Rehydration Therapy)
|5.||Drug Therapy (Chemotherapy)